====== Early-term neonate ======


Early-term [[neonate]]s (with a gestational age (GA) of 37 and 0/7 weeks to 38 and 6/7 weeks) face higher morbidities, including respiratory and neurodevelopmental issues, than full-term (39 and 0/7 weeks to 40 and 6/7 weeks) infants.
----
A [[retrospective]] study was conducted on [[neonate]]s born from January 2021-June 2022, excluding those with specific conditions. Evaluated factors included [[gestational age]], birth weight, [[bilirubin]] levels, [[Glucose-6-phosphate dehydrogenase]] [[deficiency]], and [[feeding]] type, with [[phototherapy]] given as per [[https://publications.aap.org/pediatrics/article/150/3/e2022058859/188726/Clinical-Practice-Guideline-Revision-Management-of|American Academy of Pediatrics guidelines]]. Of 1085 neonates, 356 met the criteria. When stratifying the neonates based on the need for phototherapy, a higher proportion of early-term neonates required phototherapy compared to full-term (p < 0.05). After factoring in various risks (GA; birth weight; gender; feeding type; G6PD deficiency; transcutaneous bilirubin levels at 24 h and 24-48 h postpartum; maternal diabetes; and the presence of [[caput succedaneum]] or [[cephalohematoma]]), [[early-term neonate]]s were more likely to need phototherapy than full-term babies (OR: 2.15, 95% CI: 1.21 to 3.80). The optimal cut-off for transcutaneous bilirubin levels 24-48 h postpartum that were used to predict phototherapy need was 9.85 mg/dl. In conclusion, [[early-term neonate]]s are at a greater risk for developing jaundice and requiring phototherapy than [[full-term neonate]]s. Monitoring [[bilirubin]] 24-48 h postpartum enhances early prediction and intervention
((Tan TJ, Chen WJ, Lin WC, Yang MC, Tsai CC, Yang YN, Yang SN, Liu HK. [[Early-Term Neonate]]s Demonstrate a Higher Likelihood of Requiring [[Phototherapy]] Compared to Those Born Full-Term. Children (Basel). 2023 Nov 16;10(11):1819. doi: 10.3390/children10111819. PMID: 38002910; PMCID: PMC10670379.)).